|
I.V. Menshikova
Osteoarthrosis And Metabolic Syndrome
|
№s1-12 / 2012
|
|
N.V. Galtseva
Effect Of Dosed Saunatherapy On Energy Metabolism Of Patients With Metabolic Syndrome
|
№10 / 2012
|
|
Ye.V. Golovanova
Thiogamma In Nonalcoholic Fatty Liver Disease
|
№7 / 2012
|
|
N.V. Vorohobina, A.V. Kuznetsova
Place Of Dibcor® In The Treatment Of Patients With Type 2 Diabetes Mellitus And Metabolic Syndrome
|
№3 / 2012
|
|
O.A. Mubarakshina
Modern Approaches To Treatment Of Metabolic Syndrome: Role Cardioselective Beta-blockers
|
№16 / 2011
|
|
Kovalenko LV, Belotserkovtseva LD, Korneeva EV
Clinical Experience With Drug Vitrum Cardio Omega-3 In The Correction Of Metabolic Disorders In Women With Early Menopause
|
№8 / 2011
|
|
A.M. Shilov, A.O. Osia, M.S. Dulayeva, I.V. Yeremina
Pathophysiological Features Of Treatment Of Arterial Hypertension And Disorders Of Carbohydrate Metabolism
|
№5 / 2011
|
|
Shishkova V.N.
Current Approaches To Therapy Type 2 Diabetes – Effect On Insulin Resistance
|
№3 / 2011
|
|
Severova M.M., Lopatkina T.N., Russkih A.V., Fomin V.V.
Nonalcoholic Steatohepatitis: Diagnosis And Treatment Based On Risk Factors
|
№2 / 2011
|
|
O.M. Drapkina, O.N. Korneev
Nonalcoholic Fatty Liver Disease And Cardiovascular Risk: Influence Of Female Sex
|
№15 / 2010
|
|
E.S. Vyuchnova, I.V. Maev, S.M. Babina
Experience Of Use Of Hepabene In The Treatment Of Non-alcoholic Steatohepatitis
|
№12 / 2010
|
|
O. Drapkina, D. Tutnov
Optimization Of Antihypertensive Therapy In Patients With Non-alcoholic Fatty Liver Disease
|
№10 / 2010
|
Русский
